Advertisement
Advertisement
XOMA
XOMA Royalty Corporation Common Stock
26.91
USDSponsored
-0.06
-0.21%
Feb 04, 15:59 UTC -5
Closed
After-Market
26.91
0.00
-0.01%
XOMA Earnings Reports
Positive Surprise Ratio
XOMA beat 19 of 40 last estimates.
48%
Next Report
Date of Next Report
Mar 05, 2026
Estimate for Q4 25 (Revenue/ EPS)
$11.35M
/-$0.15
Implied change from Q3 25 (Revenue/ EPS)
+21.40%
/-121.43%
Implied change from Q4 24 (Revenue/ EPS)
+30.27%
/-66.67%
XOMA Royalty Corporation Common Stock earnings per share and revenue
On Nov 12, 2025, XOMA reported earnings of 0.70 USD per share (EPS) for Q3 25, beating the estimate of -0.04 USD, resulting in a 1815.69% surprise. Revenue reached 9.35 million, compared to an expected 11.70 million, with a -20.06% difference. The market reacted with a -2.52% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 11.35 million USD, implying an decrease of -121.43% EPS, and increase of 21.40% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
Amgen Inc
Report Date
Feb 03, 2026 For Q4 25
Estimate
$4.82
Actual
$5.29
Surprise
+9.56%
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.82
Actual
$11.44
Surprise
+5.65%
Bio-Techne Corp.
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.44
Actual
$0.46
Surprise
+3.95%
Twist Bioscience Corporation Common Stock
Report Date
Feb 02, 2026 For Q1 26
Estimate
-$0.43
Actual
-$0.50
Surprise
-14.00%
Mesoblast Limited - ADR
Report Date
Jan 29, 2026 For Q1 26
Estimate
-$0.06
Actual
-$0.07
Surprise
-5.90%
AYTU BioPharma, Inc. Common Stock
Report Date
Feb 03, 2026 For Q2 26
Estimate
-$0.61
Actual
-$1.05
Surprise
-71.57%
FAQ
What were XOMA Royalty Corporation Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, XOMA Royalty Corporation Common Stock reported EPS of $0.70, beating estimates by 1815.69%, and revenue of $9.35M, -20.06% below expectations.
How did the market react to XOMA Royalty Corporation Common Stock's Q3 2025 earnings?
The stock price moved down -2.52%, changed from $34.49 before the earnings release to $33.62 the day after.
When is XOMA Royalty Corporation Common Stock expected to report next?
The next earning report is scheduled for Mar 05, 2026.
What are the forecasts for XOMA Royalty Corporation Common Stock's next earnings report?
Based on 7
analysts, XOMA Royalty Corporation Common Stock is expected to report EPS of -$0.15 and revenue of $11.35M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement